Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Clinical Trial to Examine the Pain Relief of PH-797804 Alone Or With Naproxen in Subjects With Osteoarthritis of the Knee

ClinicalTrials.gov ID: NCT01102660

Public ClinicalTrials.gov record NCT01102660. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 5:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Double-Dummy, Placebo And Active Controlled Two Period Four Treatment Cross-Over Clinical Trial To Examine The Pain Relief Of PH-797804 Alone Or With Naproxen In Subjects With Flare-Enriched Osteoarthritis Of The Knee

Study identification

NCT ID
NCT01102660
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
172 participants

Conditions and interventions

Conditions

Interventions

  • PH-797804 Drug
  • Placebo Drug
  • Naproxen Drug
  • Naproxen + PH-797804 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2010
Primary completion
Jan 31, 2011
Completion
Feb 28, 2011
Last update posted
Aug 21, 2014

2010 – 2011

United States locations

U.S. sites
26
U.S. states
13
U.S. cities
23
Facility City State ZIP Site status
Pfizer Investigational Site Paramount California 90723
Pfizer Investigational Site Spring Valley California 91978
Pfizer Investigational Site Valley Village California 91607
Pfizer Investigational Site Daytona Beach Florida 32117
Pfizer Investigational Site Ormond Beach Florida 32174
Pfizer Investigational Site Plantation Florida 33317
Pfizer Investigational Site Plantation Florida 33324
Pfizer Investigational Site South Miami Florida 33143
Pfizer Investigational Site Gurnee Illinois 60031
Pfizer Investigational Site Overland Park Kansas 66211
Pfizer Investigational Site Overland Park Kansas 66212
Pfizer Investigational Site Overland Park Kansas 66215
Pfizer Investigational Site Prairie Village Kansas 66206
Pfizer Investigational Site Wichita Kansas 67206
Pfizer Investigational Site Fall River Massachusetts 02721
Pfizer Investigational Site Hyannis Massachusetts 02601
Pfizer Investigational Site New Bedford Massachusetts 02740
Pfizer Investigational Site St Louis Missouri 63141
Pfizer Investigational Site Rochester New York 14609
Pfizer Investigational Site Wilmington North Carolina 28401
Pfizer Investigational Site Kettering Ohio 45429
Pfizer Investigational Site Pawtucket Rhode Island 02860
Pfizer Investigational Site Mt. Pleasant South Carolina 29464
Pfizer Investigational Site New Tazewell Tennessee 37825
Pfizer Investigational Site Dallas Texas 75235
Pfizer Investigational Site San Antonio Texas 78209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01102660, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 21, 2014 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01102660 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →